Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
5 Breakout Stars in Ongoing television Series- What you need to know about flu treatments as cases spike across the US
- Pulsars to the extreme: Spinning dead stars found blasting radio signals from the 'edge of their magnetic reach'
- Four Dead in Last Month From Animal Attacks in Nepal
- Argentina reportedly delaying embassy move over Israeli company's oil project near Falklands
- Wegmans recalls mixed nuts over salmonella contamination fears
- Sexual violence is being used as a weapon in Sudan's war, doctors group says
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Pick Your #1 Sort Of Espresso
